Facial Plastic Surgery Controversies: Keloids

Kofi Boahene; Anthony E Brissett; Lamont R Jones

doi:10.1016/j.fsc.2017.12.001

Facial Plastic Surgery Controversies: Keloids

Facial Plast Surg Clin North Am. 2018 May;26(2):105-112. doi: 10.1016/j.fsc.2017.12.001.

Authors

Kofi Boahene¹, Anthony E Brissett², Lamont R Jones³

Affiliations

¹ Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institute, 601 North Caroline Street, Baltimore, MD 21287, USA.
² Division of Facial Plastic and Reconstructive Surgery, Institute of Academic Medicine, Houston Methodist ENT and Facial Plastic Surgery Associates, Houston Methodist Hospital, 6550 Fannin Street, Suite 1703, Huston, TX 77030, USA.
³ Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. Electronic address: Ljones5@hfhs.org.

PMID: 29636144
DOI: 10.1016/j.fsc.2017.12.001

Abstract

There are more than 11 million people in the world affected with keloids. Nevertheless, there is a lack of agreement in keloid management. Moreover, keloid research has left gaps in the understanding of its pathogenesis. Six questions are answered by 3 clinical scientists in an attempt to address common keloid controversies.

Keywords: Fibroproliferative tumor; Keloid; Keloid prophylaxis; Keloid risk factors; Keloid treatment.

Publication types

Review

MeSH terms

Face / surgery*
Humans
Keloid / surgery*
Plastic Surgery Procedures / methods*
Surgery, Plastic